Bigfoot Biomedical raises $57M to help it diabetes administration tech


Bigfoot Biomedical announced today that it has received $ 57 million in funding to commercialize its diabetes management program.

Madryn Asset Management provided funding for Bigfoot, which, according to a press release, is developing the Bigfoot Unity Diabetes Management Program to simplify and connect aspects of insulin management to enable personalized, proactive and remote patient care. The Bigfoot Unity program offers Smar-Tpen-Caps to aid decision-making about insulin dose and allow patients to easily follow doctor’s instructions.

You can find the full story on our sister site Drug Delivery Business News.